09/02/2015 - 9:44am

he campaign is being undertaken in partnership with the American Chronic Pain Association, the Pain Community, the U.S. Pain Foundation and the American Academy of Pain Management.

09/01/2015 - 3:08pm

PrescribeMedicare is meant to serve as a tool for patients in 2016 when open enrollment for plan choices begins.

08/31/2015 - 3:31pm

The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.

08/28/2015 - 10:31am

Mylan will now move forward with its plans to tender a formal offer directly to Perrigo’s shareholders. 

08/27/2015 - 4:53pm

Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths. 

08/26/2015 - 2:30pm

Mylan this week announced the launch of its generic version of Pfizer’s Zosyn (piperacillin and tazobactam) injection.

08/25/2015 - 1:50pm
According to GlobalData’s report, the market is set to grow from $29.4 billion in 2014 to $47.9 billion by 2020, which represents a compound annual growth rate of 8.5%.
08/24/2015 - 7:49am

Camber Pharmaceuticals last week announced its introduction of its entecavir tablet in 0.5- and 1-mg dosage strengths.

08/23/2015 - 6:34pm

IMS Health’s Doug Long gave an overview of the present state of the U.S. pharmaceutical market and where it might be headed in the coming months and years at NACDS Total Store Expo on Sunday.